Xuedong An
About
Xuedong An is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology.
According to data from OpenAlex, Xuedong An has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Epidemiology. Recurrent topics in Xuedong An's work include Ginseng Biological Effects and Applications (7 papers), Retinal Diseases and Treatments (7 papers) and COVID-19 Clinical Research Studies (6 papers). Xuedong An is often cited by papers focused on Ginseng Biological Effects and Applications (7 papers), Retinal Diseases and Treatments (7 papers) and COVID-19 Clinical Research Studies (6 papers). Xuedong An collaborates with scholars based in China, Australia and Türkiye. Xuedong An's co-authors include Fengmei Lian, Hangyu Ji, Cunqing Yang, Xuefei Zhao, Wenjie Sun, Shenghui Zhao, Xiaolin Tong, De Jin, Liyun Duan and Yingying Duan and has published in prestigious journals such as Journal of Ethnopharmacology, Frontiers in Pharmacology and Biomedicine & Pharmacotherapy.
In The Last Decade
Xuedong An
42 papers receiving 1.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Xuedong An China | 17 | 339 | 195 | 183 | 173 | 143 | 48 | 1.1k | ||
| Mahboobeh Sadat Hosseini Iran | 16 | 323 1.0× | 85 0.4× | 263 1.4× | 213 1.2× | 147 1.0× | 46 | 1.3k | ||
| Željko Romić Croatia | 21 | 269 0.8× | 80 0.4× | 192 1.0× | 119 0.7× | 183 1.3× | 69 | 1.4k | ||
| Haiqiang Yao China | 15 | 502 1.5× | 129 0.7× | 201 1.1× | 157 0.9× | 100 0.7× | 27 | 1.0k | ||
| Amir Hooshang Mohammadpour Iran | 18 | 231 0.7× | 96 0.5× | 120 0.7× | 81 0.5× | 81 0.6× | 101 | 1.1k | ||
| Chunsheng Zhu China | 16 | 469 1.4× | 107 0.5× | 203 1.1× | 173 1.0× | 122 0.9× | 41 | 1.0k | ||
| Agnieszka Seremak‐Mrozikiewicz Poland | 20 | 326 1.0× | 121 0.6× | 97 0.5× | 61 0.4× | 88 0.6× | 169 | 1.5k | ||
| Yu‐Xiang Li China | 24 | 474 1.4× | 109 0.6× | 103 0.6× | 123 0.7× | 122 0.9× | 54 | 1.3k | ||
| Thakur Uttam Singh India | 19 | 419 1.2× | 80 0.4× | 80 0.4× | 138 0.8× | 118 0.8× | 66 | 1.3k | ||
| Mahbubeh Setorki Iran | 16 | 289 0.9× | 161 0.8× | 223 1.2× | 95 0.5× | 98 0.7× | 77 | 1.4k | ||
| Zehuai Wen China | 18 | 202 0.6× | 307 1.6× | 63 0.3× | 87 0.5× | 116 0.8× | 111 | 1.2k |
Countries citing papers authored by Xuedong An
Since
Specialization
Citations
This map shows the geographic impact of Xuedong An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuedong An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuedong An more than expected).
Fields of papers citing papers by Xuedong An
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Xuedong An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuedong An. The network helps show where Xuedong An may publish in the future.
Co-authorship network of co-authors of Xuedong An
This figure shows the co-authorship network connecting the top 25 collaborators of Xuedong An. A scholar is included among the top collaborators of Xuedong An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuedong An. Xuedong An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sun, Wenjie, et al.. (2025). Comparison of the effectiveness and safety of GLP-1 receptor agonists for type 2 diabetes mellitus patients with overweight/obesity: A systematic review and network meta-analysis. Diabetes Research and Clinical Practice. 222. 111999–111999.
2.
Zhao, Xuefei, Linlin Jiang, Shanshan Tang, et al.. (2025). Understanding the interplay between COVID-19 and diabetes: insights for the post-pandemic era. Frontiers in Endocrinology. 16. 1599969–1599969.
3.
An, Xuedong, et al.. (2025). Comparison of three types of drugs for cardiovascular and renal benefits in type 2 diabetes mellitus. World Journal of Diabetes. 16(11). 111280–111280.
4.
Gao, Qing, Linlin Jiang, Yuting Sun, et al.. (2025). Oxidative stress: from molecular studies to clinical intervention strategies. Frontiers in Molecular Biosciences. 12. 1638042–1638042.
5.
Yang, Lin, et al.. (2025). A new perspective on protecting the blood-retinal barrier against injury in diabetic retinopathy: mitophagy. Frontiers in Endocrinology. 16. 1617797–1617797.
6.
Kang, Xiaomin, De Jin, Hangyu Ji, et al.. (2024). The Clinical Efficacy of Gegen Qinlian Decoction in Treating Type 2 Diabetes is Positively Correlated with the Dose of Coptidis rhizoma: Three Randomized, Doubleblind, Dose-Parallel Controlled Clinical Trials. Drug Design Development and Therapy. Volume 18. 5573–5582.
7.
An, Xuedong, Yuehong Zhang, Wenjie Sun, et al.. (2024). Early effective intervention can significantly reduce all-cause mortality in prediabetic patients: a systematic review and meta-analysis based on high-quality clinical studies. Frontiers in Endocrinology. 15. 1294819–1294819.
8.
Sun, Wenjie, Xuedong An, Yuehong Zhang, et al.. (2024). Autophagy-dependent ferroptosis may play a critical role in early stages of diabetic retinopathy. World Journal of Diabetes. 15(11). 2189–2202.
9.
Sun, Yuting, Hangyu Ji, Wenjie Sun, Xuedong An, & Fengmei Lian. (2024). Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases. European Journal of Internal Medicine. 131. 3–14.
10.
Zhao, Xuefei, Xuedong An, Cunqing Yang, et al.. (2023). The crucial role and mechanism of insulin resistance in metabolic disease. Frontiers in Endocrinology. 14. 1149239–1149239.
11.
Sun, Yuting, De Jin, Ziwei Zhang, et al.. (2023). N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1866(4). 194967–194967.
12.
An, Xuedong, Xin‐Min Li, Yan Li, et al.. (2023). The rational dose for MaXingShiGan decoction is crucial for its clinical effectiveness in treating bronchial pneumonia: three randomized, double-blind, dose-parallel controlled clinical studies. Frontiers in Pharmacology. 14. 1279519–1279519.
13.
Yang, Cunqing, Xuefei Zhao, Xuedong An, et al.. (2023). Axonal transport deficits in the pathogenesis of diabetic peripheral neuropathy. Frontiers in Endocrinology. 14. 1136796–1136796.
14.
Zhang, Yuehong, De Jin, Xuedong An, et al.. (2022). The Long-Term Effects of Non-Pharmacological Interventions on Diabetes and Chronic Complication Outcomes in Patients With Hyperglycemia: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 13. 838224–838224.
15.
Sha, Di, Xuedong An, Bing Pang, et al.. (2022). Yiqi Tongluo Fang could preventive and delayed development and formation of diabetic retinopathy through antioxidant and anti-inflammatory effects. Biomedicine & Pharmacotherapy. 148. 112254–112254.
16.
Duan, Liyun, De Jin, Xuedong An, et al.. (2021). The Potential Effect of Rhizoma coptidis on Polycystic Ovary Syndrome Based on Network Pharmacology and Molecular Docking. Evidence-based Complementary and Alternative Medicine. 2021. 1–12.
17.
Jin, De, Xuedong An, Yuqing Zhang, et al.. (2021). Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking. Frontiers in Pharmacology. 12. 602218–602218.
18.
Wu, Haoran, Jiaxing Tian, Jiangquan Liao, et al.. (2020). Efficacy and safety assessment of traditional Chinese medicine for metabolic syndrome. BMJ Open Diabetes Research & Care. 8(1). e001181–e001181.
19.
An, Xuedong, De Jin, Liyun Duan, et al.. (2020). Direct and indirect therapeutic effect of traditional Chinese medicine as an add-on for non-proliferative diabetic retinopathy: a systematic review and meta-analysis. Chinese Medicine. 15(1). 99–99.
20.
An, Xuedong, et al.. (2012). Oral Chinese Herbal Medicine for Improvement of Quality of Life in Patients with Stable Chronic Obstructive Pulmonary Disease: A Systematic Review. The Journal of Alternative and Complementary Medicine. 18(8). 731–743.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Mahboobeh Sadat Hosseini Breakdown of academic impact, for papers by Željko Romić Breakdown of academic impact, for papers by Haiqiang Yao Breakdown of academic impact, for papers by Amir Hooshang Mohammadpour Breakdown of academic impact, for papers by Chunsheng Zhu Breakdown of academic impact, for papers by Agnieszka Seremak‐Mrozikiewicz Breakdown of academic impact, for papers by Yu‐Xiang Li Breakdown of academic impact, for papers by Thakur Uttam Singh Breakdown of academic impact, for papers by Mahbubeh Setorki Breakdown of academic impact, for papers by Zehuai Wen